sphingotest® bio-ADM®
The sphingotest® bio-ADM® is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of bioactive Adrenomedullin 1-52 in human EDTA plasma.
Bioactive Adrenomedullin 1-52 (bio-ADM*) measurement in conjunction with clinical assessments and other laboratory findings is used as an aid in the prediction of the need of vasopressor therapy in patients with sepsis or septic shock.
The sphingotest® bio-ADM® is intended for use by professional users in laboratory settings.
Assay technology
The microtiter assay is based on a chemiluminescence sandwich immunoassay technology, which is a standard tool in analytical research and diagnostic testing laboratories.
Product Instruction for Use is available upon request.
| Key features | |
|---|---|
| Product type | non-automated immunoluminometric assay (ILMA) |
| Product status | CE IVD |
| Sample type | EDTA plasma samples |
| Samples volume | 100 µL |
| Kit size | 1 x 96 well plate |
| Assay incubation time | approx. 1 hour |
| Detection range | 11 - 1094 pg/mL |
| Upper normal range | 29 pg/mL (90% CI 27 pg/mL - 38 pg/mL) |
| No high dose hook effect | up to 10 µg/mL |
Special material required but not provided:
- sphingotest® Lightning (cat. No. LIG30). Read more here
- MTP flash-type luminometer with two injectors. Read more here
- MTP flash-type luminometer compatible software and validation tool. Read more here
Request a quote
The sphingotest® bio-ADM® is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of bioactive Adrenomedullin 1-52 in human EDTA plasma.
Please do not hesitate to contact us if you are interested in our products or need support.
Contact us at + 49 (0)330 220 56 5 – 0, order@sphingotec.com
*Disclaimer
Sphingotest® penKid®, sphingotest® bio-ADM®, sphingotest® DPP3 are offered for in vitro diagnostics. “penKid”, “bio-ADM” and “DPP3” represent the analytes Proenkephalin A 119-159, bioactive Adrenomedullin 1-52, and Dipeptidyl Peptidase 3, respectively.